Related Experiment Video
Updated: Dec 17, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Clostridium difficile infection after antibiotic use.
Heather L Brown1, Gerald A Erickson
1Heather L. Brown is director of clinical education for the PA program at Brenau University in Gainesville, Ga., and works in emergency and urgent care medicine in Atlanta, Ga. Gerald A. Erickson, Jr., is an adjunct clinical assistant professor and accreditation consultant at Lenoir Rhyne University in Hickory, N.C. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Antibiotic use can lead to Clostridium difficile superinfections in patients. Clinicians must carefully select antibiotics to minimize patient risks and prevent adverse outcomes.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacology
Background:
- Antibiotics are crucial for treating bacterial infections.
- Antibiotic therapy can disrupt the normal gut microbiota.
- This disruption creates an opportunity for opportunistic pathogens to proliferate.
Observation:
- Patients receiving antibiotics are at risk for developing Clostridium difficile infections.
- Clostridium difficile is a common cause of antibiotic-associated diarrhea.
- Superinfections can lead to significant patient morbidity.
Findings:
- The use of broad-spectrum antibiotics increases the risk of Clostridium difficile superinfection.
- Specific antibiotic classes are more strongly associated with C. difficile than others.
- Prompt recognition and management of C. difficile are essential.
Implications:
- Judicious antibiotic prescribing is vital to mitigate superinfection risks.
- Developing strategies to prevent C. difficile colonization during antibiotic treatment is needed.
- Understanding antibiotic-microbiota interactions can inform safer treatment protocols.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Antibiotic Selection
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Development of Antibiotic Resistance

